Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
8.41
+0.37 (4.60%)
At close: Nov 7, 2025, 4:00 PM EST
8.25
-0.16 (-1.90%)
After-hours: Nov 7, 2025, 4:40 PM EST
Mersana Therapeutics Market Cap
Mersana Therapeutics has a market cap or net worth of $41.97 million as of November 7, 2025. Its market cap has decreased by -83.39% in one year.
Market Cap
41.97M
Enterprise Value
-14.38M
1-Year Change
-83.39%
Ranking
Category
Stock Price
$8.41
Market Cap Chart
Since June 28, 2017, Mersana Therapeutics's market cap has decreased from $317.00M to $41.97M, a decrease of -86.76%. That is a compound annual growth rate of -21.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 42.00M | -76.23% |
| Dec 31, 2024 | 176.70M | -36.85% |
| Dec 29, 2023 | 279.80M | -52.15% |
| Dec 30, 2022 | 584.70M | 30.72% |
| Dec 31, 2021 | 447.30M | -75.46% |
| Dec 31, 2020 | 1.82B | 564.25% |
| Dec 31, 2019 | 274.40M | 190.06% |
| Dec 31, 2018 | 94.60M | -74.69% |
| Dec 29, 2017 | 373.80M | 17.92% |
| Jun 28, 2017 | 317.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |